Oberweis Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Oberweis Asset Management's ANIP Position: Q3 2026 in Review
Oberweis Asset Management increased its ANI Pharmaceuticals (ANIP) stake by 10% in Q3 2026, buying an estimated $2.06M and bringing the position to 292,034 shares worth $21.2M. The position accounts for 0.48% of the portfolio, ranked #85.
Oberweis Asset Management first reported a position in ANIP in Q4 2014 and has held it in 17 quarters since. The position peaked at $22M in Q2 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Oberweis Asset Management held 292,034 shares of ANI Pharmaceuticals worth $21.2M as of Q3 2026.
- Oberweis Asset Management bought 26,728 ANI Pharmaceuticals shares in Q3 2026, an estimated $2.06M.
- ANI Pharmaceuticals made up 0.48% of Oberweis Asset Management's portfolio in Q3 2026, its #85 holding.
- Oberweis Asset Management first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 17 quarters since.
- Oberweis Asset Management's ANI Pharmaceuticals position peaked at $22M in Q2 2026.
- 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Oberweis Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.